Life Sciences, funding, Fragile X

Avalon’s aFraxis Raises $750K

Bruce V. Bigelow 6/10/09

San Diego’s aFraxis has raised $750,000 in early stage funding, according to a recent regulatory filing submitted to the Securities and Exchange Commission. The startup backed by San Diego’s Avalon Ventures was founded in 2007, and is focused on developing treatments for Fragile X syndrome and autism. Avalon’s Jay Lichter is listed as chief executive and  director. A newsletter published by the Massachusetts-based Fraxa Research Foundation has reported that aFraxis is exploring a treatment strategy identified by Susumu Tonegawa, a Nobel laureate and MIT professor of biology and neuroscience.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call 858-202-0492